Literature DB >> 4081126

Isolation and partial characterization of an endothelial cell growth factor from the bovine kidney: homology with basic fibroblast growth factor.

A Baird, F Esch, P Böhlen, N Ling, D Gospodarowicz.   

Abstract

Two kidney-derived mitogens have been isolated by ion exchange, heparin-Sepharose and reverse-phase high-performance liquid chromatography on the basis of their capacity to stimulate the proliferation of bovine vascular endothelial cells in vitro. Gas phase sequence analysis identified the amino terminal sequences His-Phe-Lys-Asp-Pro-Lys-Arg-Leu-Tyr-X-Lys-Asn-Gly-Gly-Phe-Phe-Leu and His-Phe-Lys-Asp-Pro-Lys-Arg-Leu, respectively. The sequences are identical to residues 16-32 and 16-23 of bovine basic pituitary Fibroblast Growth Factor (FGF). The possibility that these kidney-derived mitogens are related, if not identical, to pituitary basic FGF is supported by the observations that they have similar molecular weights (15-16 kDa), similar retention behavior on all steps of chromatography and similar amino acid compositions, and they share at least some structural homology. Moreover, the kidney-derived growth factors, like basic FGF, are potent stimulators of capillary endothelial cells, granulosa cells, adrenocortical cells and vascular smooth-muscle cells (ED50 = 50 pg). The results demonstrate the existence of a kidney-derived FGF and suggest that at least some of the mitogenic, angiogenic and neovascularising activities described to be present in the kidney are due to the presence of an FGF-like molecule in this tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4081126     DOI: 10.1016/0167-0115(85)90061-8

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

Review 1.  Polypeptide growth factors and the kidney: a developmental perspective.

Authors:  E D Avner
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

2.  Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells.

Authors:  S M Schwartz; L Foy; D F Bowen-Pope; R Ross
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

3.  Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases.

Authors:  M Klagsbrun; S Smith; R Sullivan; Y Shing; S Davidson; J A Smith; J Sasse
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.

Authors:  J Folkman; M Klagsbrun; J Sasse; M Wadzinski; D Ingber; I Vlodavsky
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Basic fibroblast growth factor can mediate the early inductive events in renal development.

Authors:  A O Perantoni; L F Dove; I Karavanova
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons.

Authors:  K Unsicker; H Reichert-Preibsch; R Schmidt; B Pettmann; G Labourdette; M Sensenbrenner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.

Authors:  J Floege; E Eng; V Lindner; C E Alpers; B A Young; M A Reidy; R J Johnson
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

8.  Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.

Authors:  S J Braunhut; L J Gudas; T Kurokawa; J Sasse; P A D'Amore
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

9.  Production of a heparin-binding angiogenesis factor by the embryonic kidney.

Authors:  W Risau; P Ekblom
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

10.  Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer.

Authors:  Sahar Hakamy; Mourad Assidi; Mohammad A Jafri; Taoufik Nedjadi; Heba Alkhatabi; Abrar Al-Qahtani; Jaudah Al-Maghrabi; Khalid Sait; Mohammed Al-Qahtani; Abdelbaset Buhmeida; Adeel Chaudhary
Journal:  Libyan J Med       Date:  2021-12       Impact factor: 1.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.